Curcumin: A natural modulator of immune cells in systemic lupus erythematosus
- PMID: 29180127
- DOI: 10.1016/j.autrev.2017.11.016
Curcumin: A natural modulator of immune cells in systemic lupus erythematosus
Abstract
Curcumin is a polyphenol natural product isolated from turmeric, interacting with different cellular and molecular targets and, consequently, showing a wide range of pharmacological effects. Recent preclinical and clinical trials have revealed immunomodulatory properties of curcumin that arise from its effects on immune cells and mediators involved in the immune response, such as various T-lymphocyte subsets and dendritic cells, as well as different inflammatory cytokines. Systemic lupus erythematosus (SLE) is an inflammatory, chronic autoimmune-mediated disease characterized by the presence of autoantibodies, deposition of immune complexes in various organs, recruitment of autoreactive and inflammatory T cells, and excessive levels of plasma proinflammatory cytokines. The function and numbers of dendritic cells and T cell subsets, such as T helper 1 (Th1), Th17, and regulatory T cells have been found to be significantly altered in SLE. In the present report, we reviewed the results of in vitro, experimental (pre-clinical), and clinical studies pertaining to the modulatory effects that curcumin produces on the function and numbers of dendritic cells and T cell subsets, as well as relevant cytokines that participate in SLE.
Keywords: Curcumin; Dendritic cell; Regulatory T cell; Systemic lupus erythematosus; T helper 1; T helper 17.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Dendritic cells in systemic lupus erythematosus.Int Rev Immunol. 2010 Apr;29(2):184-209. doi: 10.3109/08830181003602507. Int Rev Immunol. 2010. PMID: 20367140 Free PMC article. Review.
-
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.Cytokine. 2015 Apr;72(2):146-53. doi: 10.1016/j.cyto.2014.12.027. Epub 2015 Jan 31. Cytokine. 2015. PMID: 25647269
-
Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients.Arthritis Rheumatol. 2017 Oct;69(10):2029-2037. doi: 10.1002/art.40180. Epub 2017 Aug 25. Arthritis Rheumatol. 2017. PMID: 28605137
-
The interplay of dendritic cell subsets in systemic lupus erythematosus.Immunol Cell Biol. 2002 Oct;80(5):484-8. doi: 10.1046/j.1440-1711.2002.01112.x. Immunol Cell Biol. 2002. PMID: 12225385 Review.
-
Cytokines in systemic lupus erythematosus.Curr Mol Med. 2009 Apr;9(3):242-54. doi: 10.2174/156652409787847263. Curr Mol Med. 2009. PMID: 19355907 Free PMC article. Review.
Cited by
-
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved.Antioxidants (Basel). 2024 Apr 18;13(4):486. doi: 10.3390/antiox13040486. Antioxidants (Basel). 2024. PMID: 38671933 Free PMC article. Review.
-
The properties and mechanism of action of plant immunomodulators in regulation of immune response - A narrative review focusing on Curcuma longa L., Panax ginseng C. A. Meyer and Moringa oleifera Lam.Heliyon. 2024 Mar 21;10(7):e28261. doi: 10.1016/j.heliyon.2024.e28261. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38586374 Free PMC article. Review.
-
Curcumin as a regulator of Th17 cells: Unveiling the mechanisms.Food Chem (Oxf). 2024 Mar 12;8:100198. doi: 10.1016/j.fochms.2024.100198. eCollection 2024 Jul 30. Food Chem (Oxf). 2024. PMID: 38525269 Free PMC article. Review.
-
Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials.BMC Med. 2024 Mar 13;22(1):110. doi: 10.1186/s12916-024-03303-4. BMC Med. 2024. PMID: 38475833 Free PMC article.
-
Randomised Clinical Trial Study: The Combination of Vitamin D and Curcumin Piperine Attenuates Disease Activity and Pro-inflammatory Cytokines Levels Insystemic Lupus Erythematosus Patients.Curr Rheumatol Rev. 2024;20(5):586-594. doi: 10.2174/0115733971276106231226071002. Curr Rheumatol Rev. 2024. PMID: 38299416 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical